Family Medicine Summit (formerly ASA)
Webinars
Tools & Resources
Find a Family Physician
PEIP Conference
GoMainpro
Member Support
What's Up Doc Research Showcase

News & Events

TFP #261 – Antivirals for COVID-19

Clinical Question: Do treatments such as remdesivir or other anti-virals change patient outcomes in COVID-19 patients? Bottom Line: To date, published RCTs have not demonstrated benefit of treating COVID-19 patients with remdesivir, lopinavir-ritonavir or oseltamivir.  There are signals of potential benefits from one interim analysis of remdesivir and non-statistically different results, but more research is needed. Full publication of studies…

Read More

TFP #260 – Are there tools to help assess dyspnea virtually?

Clinical Question: Are there any techniques (like the Roth Score) to augment a typical history when assessing dyspnea/pneumonia over the phone or by video? Bottom Line: Unfortunately, no specific technique, including the Roth Score, is reliable in assuring dyspneic patients are not at risk and safe to stay home. Furthermore, no studies have evaluated dyspnea assessment in…

Read More

TFP #259 – Unmasking the evidence around masks for healthcare workers

Clinical Question: Is there a difference between mask types in preventing viral respiratory infections for healthcare workers? Bottom Line: In healthcare workers; Surgical masks and respirators (N95) appear to provide similar protection against viral infections, with N95 masks having slightly lower, but not statistically different, infection rates in the wearer (~1-2%).  Cloth masks are less effective than…

Read More

April President’s Message – Better Together

Read Full eNews To all my colleagues from across the province, I want to start by extending my gratitude to all of you. Thank you for continuing the work that you do given the constraints and challenges the COVID-19 pandemic has created. There is continued evolution in terms of how we deliver care to our…

Read More

TFP #258 – Stealth style transmission? Covert data on COVID-19

Clinical Question: What is the evidence for asymptomatic transmission of COVID-19 (including those who will remain asymptomatic and those who are early and not symptomatic yet)? Bottom Line: Transmission of COVID-19 can occur in people who are currently asymptomatic. Case reports suggest this occurs in 6-13% of cases, although modelling suggests this might be higher. The importance of…

Read More

TFP #257 – A rushed introduction to an uninvited guest

Clinical Question: COVID-19: What are the presenting symptoms, clinical course, and risk factors for mortality? Bottom Line: Cough and fever are the most common symptoms. Differences in testing and reporting of cases limit prognostic estimations. At minimum, 80% of cases are clinically mild. Of those hospitalized in North America, ~25% will require ICU admission. Risk factors for…

Read More

COVID 19 – Quick Links

UPDATED APRIL 14, 2020 Alberta Health Services Public Health has asked the ACFP to support regular updates to family physicians in Alberta regarding the potential outbreak of novel coronavirus. AHS, ACFP, and CPSA, will continue to share the latest information through our communication channels as it becomes available. All channels will direct you to the…

Read More

COVID-19: Upcoming CME

Wednesday, April 1 | 7:30 – 8:30 PM MDTCOVID-19: Clinical Updates Webinar, University of Calgary CME&PD Thursday, April 2 | 12:00 PM (EDT)The COVID-19 Pivot: Protecting patients and physicians during the pandemic, College of Family Physicians of Canada Thursday, April 9 | 12:00 PM (EDT)The COVID-19 Pivot: The Clinical Presentation of COVID-19 Infections and Course…

Read More

TFP #256 -Hydroxychloroquine with or without azithromycin for COVID-19

Clinical Question: Is hydroxychloroquine (with or without azithromycin) effective in treating COVID-19? Bottom Line: One nonrandomized study found that more hydroxychloroquine/azithromycin patients tested negative for virus at days 3 and 6 but clinical outcomes were not reported. One unblinded randomized trial showed no effect from hydroxychloroquine on viral or clinical outcomes. Without further evidence, hydroxychloroquine is not…

Read More

Continuing Advocacy Efforts: A Letter to Partners & Advocates

Download PDF HereMarch 25, 2020 Dear Partners and Advocates: We currently face a situation that is unprecedented for many of us. Not only are there challenges to the public health care system, but we are also tackling the ever-increasing demands the COVID-19 pandemic brings to our ability to deliver care. Through all of this, family…

Read More

March President’s Message – Into the Unknown

Read Full eNewsTo say we are in a time of change and uncertainty would be an understatement. From the unpredictable political climate of Alberta to the formal declaration of a new worldwide pandemic, there is a constellation of change that many of us have likely not experienced before. COVID-19 I have many thoughts about what…

Read More